Candel Therapeutics (CADL) Stock Surges: Regulatory Approval Sparks Investor Interest
Candel Therapeutics, Inc. (NASDAQ: CADL) experienced a significant surge in its stock valuation on the preceding trading day, showcasing an impressive increase of 42.75% and concluding at $7.28 by the market close. This notable escalation in CAL shares was instigated by the granting of regulatory approval. In a recent announcement, Canndel Therapeutics (CADL) unveiled that […]
